Millions of older people with poor vision are at risk of being misdiagnosed with mild cognitive impairments, according to a new study by the University of South Australia.
On November 25, 2021, a patient at Moorfields Eye Hospital NHS Foundation Trust became the first person in the world to get a fully digital 3D printed prosthetic eye.
The Notal Vision Monitoring Center is celebrating the ten millionth test completed by over 20,000 patients using the FDA-cleared ForeseeHome gadget, which was analyzed through artificial intelligence (AI).
Visus Therapeutics has revealed positive topline results from VIVID, the company’s Phase 2 study of three novel topical ophthalmic formulations under investigation for the treatment of presbyopia.
In a three-month study, a bionic eye developed by a team of biomedical researchers from the University of Sydney and UNSW proved to be safe and stable for long-term implantation, paving the way for human trials.
Envision will help students who are blind or visually impaired to enter college and workforce with the acquisition of the College Success Program (CSP).
AcuFocus announced that it has received an Approvable Letter from the FDA for its IC-8 small aperture IOL, which is designed for cataract patients.
Mount Sinai Health System has opened New York City's first eye stroke program to accelerate the diagnosis and treatment of patients who arrive in the emergency room with an eye stroke, a medical emergency that must be treated as soon as possible to avoid
Developing therapies for genetic forms of blindness is extremely challenging, in part because they vary so widely, but scientists from Trinity College Dublin have highlighted a target with great promise for treating a range of these conditions.
Researchers at the National Eye Institute (NEI) have discovered that power-producing organelles in the eye's photoreceptor cells, called mitochondria, function as microlenses that help channel light to these cells' outer segments where it's converted into